| scholarly article | Q13442814 |
| P50 | author | Hans Vasen | Q51123729 |
| Hans C. van Houwelingen | Q59660364 | ||
| P2093 | author name string | F Quehenberger | |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometrial cancer | Q944777 |
| P304 | page(s) | 491-496 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Journal of Medical Genetics | Q14640281 |
| P1476 | title | Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment | |
| P478 | volume | 42 |
| Q37693398 | A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers |
| Q38659629 | A comparison of cosegregation analysis methods for the clinical setting |
| Q36512734 | A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry |
| Q37089839 | A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome |
| Q35013990 | A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory |
| Q36416282 | ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes |
| Q33807931 | Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers |
| Q84551315 | Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome |
| Q38897378 | CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome |
| Q37399783 | Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome |
| Q54503214 | Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer? |
| Q38100658 | Cancer risk in Lynch Syndrome |
| Q33582756 | Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management |
| Q57285827 | Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation |
| Q50556962 | Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation. |
| Q30563768 | Cancer risks for MLH1 and MSH2 mutation carriers |
| Q57569922 | Cascade genetic testing for mismatch repair gene mutations |
| Q57569926 | Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer |
| Q37254403 | Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics |
| Q88013404 | Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study |
| Q29417133 | Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk |
| Q34051401 | Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study |
| Q33685573 | Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: A retrospective case-case study. |
| Q58408293 | Contributions récentes pour l’identification et le dépistage du syndrome de Lynch |
| Q37409157 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals |
| Q21328691 | Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients |
| Q35587019 | Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes |
| Q40239979 | Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk |
| Q34794283 | Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study |
| Q46585107 | Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study |
| Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
| Q38105276 | Do lifestyle factors influence colorectal cancer risk in Lynch syndrome? |
| Q24655053 | EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome |
| Q44595115 | Estimating cancer risk in HNPCC by the GRL method. |
| Q34514962 | Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method |
| Q48935070 | Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model |
| Q37786243 | Evaluation of the Validity and Utility of Genetic Testing for Rare Diseases |
| Q91810056 | Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees |
| Q51137586 | Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis. |
| Q34655489 | Familial colorectal cancer, beyond Lynch syndrome |
| Q38062023 | Follow-up recommendations and risk-reduction initiatives for Lynch syndrome |
| Q31139897 | Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives |
| Q36809661 | Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome |
| Q48818506 | Germline mutations in patients with multiple colorectal polyps in China |
| Q36746989 | Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). |
| Q51063696 | Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. |
| Q37221783 | Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. |
| Q56764357 | Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients? |
| Q38287107 | Hereditary and common familial colorectal cancer: evidence for colorectal screening |
| Q36990149 | Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry |
| Q33918280 | Hereditary colon cancer: lynch syndrome |
| Q38671560 | Hereditary gastrointestinal cancer. |
| Q38153188 | Hereditary ovarian and breast cancer: what have we learned? |
| Q34977063 | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management |
| Q36808349 | High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation |
| Q37716875 | History, genetics, and strategies for cancer prevention in Lynch syndrome |
| Q37753030 | Hormone prevention strategies for breast, endometrial and ovarian cancers |
| Q35760971 | Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. |
| Q43429867 | Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation |
| Q48249964 | Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial. |
| Q34280607 | Interval colon cancer in a Lynch syndrome patient under annual colonoscopic surveillance: a case for advanced imaging techniques? |
| Q33779382 | Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes |
| Q37234921 | Lynch syndrome: case report and review of the literature |
| Q39855627 | Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters. |
| Q37430836 | Management of extracolonic tumours in patients with Lynch syndrome |
| Q34988799 | Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families |
| Q58408134 | Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome |
| Q35808472 | Microsatellite instability use in mismatch repair gene sequence variant classification |
| Q90302673 | Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio |
| Q44593249 | Molecular diagnosis of endometrial cancer from uterine aspirates. |
| Q36288221 | Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome |
| Q27024662 | PMS2 monoallelic mutation carriers: the known unknown |
| Q37710179 | Pain evaluation during gynaecological surveillance in women with Lynch syndrome. |
| Q36182997 | Pancreatic cancer and a novel MSH2 germline alteration |
| Q37417652 | Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models |
| Q37348461 | Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario |
| Q43625600 | Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry |
| Q38769692 | Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes |
| Q36882484 | Prediction of germline mutations and cancer risk in the Lynch syndrome |
| Q84058811 | Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study |
| Q81524412 | Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome |
| Q35579543 | Quality of colonoscopy in Lynch syndrome |
| Q36790169 | Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer |
| Q36824964 | Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts |
| Q36758605 | Risk assessment, genetic testing, and management of Lynch syndrome |
| Q34163849 | Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma |
| Q33880380 | Risk of pancreatic cancer in families with Lynch syndrome |
| Q34346668 | Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers |
| Q30492977 | Risks of Lynch syndrome cancers for MSH6 mutation carriers |
| Q36486798 | Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome |
| Q34501718 | Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families |
| Q34344817 | Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome |
| Q33658220 | Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center |
| Q45920792 | Splice site mutations in mismatch repair genes and risk of cancer in the general population. |
| Q100402781 | Statistical approaches for meta-analysis of genetic mutation prevalence |
| Q37274864 | Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery |
| Q37751548 | TTD consensus document on the diagnosis and management of hereditary colorectal cancer. |
| Q48332104 | The Changing Landscape of Lynch Syndrome due to PMS2 Mutations. |
| Q39456907 | The Immune Biology of Microsatellite-Unstable Cancer |
| Q24655454 | The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations |
| Q58635831 | The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer |
| Q34062115 | The mutational spectrum of Lynch syndrome in cyprus |
| Q44511151 | The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome |
| Q59548976 | The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer |
| Q37326213 | Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum |
| Q35129795 | Understanding patterns of health communication in families at risk for hereditary nonpolyposis colorectal cancer: examining the effect of conclusive versus indeterminate genetic test results |
| Q36051960 | Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients. |
| Q82036391 | [Molecular pathogenesis. Its importance in targeted therapy in colorectal cancer] |
Search more.